NCT Number: NCT02425293
INCAS - Integrated Care of Asthma in Switzerland
The aim of this study was to investigate the effect of standardized patient education on asthma control. In collaboration with two health insurance companies, pharmacists and pneumologists, patients with asthma were recruited. They completed the "Asthma Control Test (ACT)" and the "Patient Assessment of Chronic Illness Care (PACIC 5A)" questionnaire to assess asthma control and patients' satisfaction with the health care service they received. Additionally, patients were offered the possibility to participate in a patient education seminar run by the Swiss lung leagues or the Swiss allergy centre (aha!). After one year, patients were asked to complete the questionnaires again. Comparisons of intraindividual changes and differences regarding ACT and PACIC 5A between patients with and without patient education were made.
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year–59 year
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- patients with clinical asthma diagnosis
- written informed consent
Exclusion criteria
- inadequate knowledge of the German language
- subjects with severe diseases with life expectancy under one year
- subjects with known Chronic Obstructive Pulmonary Disease (COPD)
Treatment and study plan
Primary outcomes
-
Comparison of patient characteristics between the intervention and the control group
Time frame: baseline
-
Comparison of asthma control between the intervention and the control group
Time frame: baseline
Asthma control is measured using the Asthma Control Test (ACT).
-
Comparison of patient satisfaction between the intervention and the control group
Time frame: baseline
Patient satisfaction is measured using the Patient Assessment of Chronic Illness Care (PACIC 5A) questionnaire.
Secondary outcomes
-
Comparison of asthma control at baseline and after one year in the intervention group.
Time frame: baseline and follow up (after one year)
Analysis of change in asthma control (using the Asthma Control Test (ACT)) in the intervention group from baseline to follow up (after one year).
-
Comparison of asthma control at baseline and after one year in the control group.
Time frame: baseline and follow up (after one year)
Analysis of change in asthma control (using the Asthma Control Test (ACT)) in the control group from baseline to follow up (after one year).
-
Comparison of patient satisfaction at baseline and after one year in the intervention group.
Time frame: baseline and follow up (after one year)
Analysis of change in patient satisfaction (using the PACIC 5A questionnaire) in the intervention group from baseline to follow up (after one year).
-
Comparison of patient satisfaction at baseline and after one year in the control group.
Time frame: baseline and follow up (after one year)
Analysis of change in patient satisfaction (using the PACIC 5A questionnaire) in the control group from baseline to follow up (after one year).
Sponsors and collaborators
Lead sponsor
Cantonal Hosptal, Baselland
Other
Registry information
Acronym: INCAS
Important dates
- Study start
- 2012
- Primary completion
- 2014
- Study completion
- 2014
- First posted
- Apr 23, 2015
- Registry last updated
- Apr 23, 2015
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
SU JOK THERAPY TO IMPROVE DYSPNEA AND INSOMNIA IN ASTHMA
NCT07746570
Asthma, Bronchial Diseases
Erzincan, Merkez, Turkey (Türkiye)
View Trial DetailsNew Approaches for Empowering Studies of Asthma in Populations of African Descent
NCT03937804
Asthma, Bronchial Diseases
Bethesda, Maryland, United States
View Trial DetailsSample Collections From the Airways of Asthmatic Patients
NCT00001888
Asthma, Bronchial Diseases
Bethesda, Maryland, United States
View Trial DetailsPharmacokinetic Profile and Safety of Fluticasone Propionate and Albuterol Sulfate in Combination When Compared to Fluticasone Propionate Multidose Dry Powder Inhaler (Fp MDPI) in Children Aged 4 to 11 Years Old
NCT06290102
Asthma, Bronchial Diseases
Mobile, Alabama, United States
View Trial Details